All IndicationsInfectious DiseaseApprovedApprovedApprovedApprovedApprovedPhase 3Phase 3Phase 2Phase 2
🦠
Influenza
4
Companies
10
Drug Programs
2
Phase 3
0
Upcoming PDUFAs
Competitors
MRNA
Moderna
Moderna flu shot
MRNA
Moderna
Moderna flu vaccine
MRNA
Moderna
mFlusiva
MRNA
Moderna
Moderna mRNA flu shot
MRNA
Moderna
Moderna mRNA flu vaccine
BNTX
BioNTech SE
Influenza and COVID-19 Combination A
SNY
Sanofi
A/H1N1 pandemic influenza vaccine (non- adjuvanted)
NVS
Novartis AG
Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008
BNTX
BioNTech SE
Investigational COVID-19 Vaccine
MRNA
Moderna
mRNA Flu vaccine
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| MRNA Moderna | Moderna flu shot | Approved | — | — | — |
| MRNA Moderna | Moderna flu vaccine | Approved | — | — | — |
| MRNA Moderna | mFlusiva | Approved | — | — | — |
| MRNA Moderna | Moderna mRNA flu shot | Approved | — | — | — |
| MRNA Moderna | Moderna mRNA flu vaccine | Approved | — | — | — |
| BNTX BioNTech SE | Influenza and COVID-19 Combination A | Phase 3 | — | — | — |
| SNY Sanofi | A/H1N1 pandemic influenza vaccine (non- adjuvanted) | Phase 3 | — | — | — |
| NVS Novartis AG | Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008 | Phase 2 | — | — | — |
| BNTX BioNTech SE | Investigational COVID-19 Vaccine | Phase 2 | — | — | — |
| MRNA Moderna | mRNA Flu vaccine | — | — | — | — |
Development Stage Distribution
Unknown
1
Approved
5
Phase 3
2
Phase 2
2
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.